Furthermore, our study suggested that the LRRC75A-AS1-hsa-miR-330-5p-CDK4/6 axis might exert its antitumor function by inhibiting the antigen presentation ability of tumor cells and by inhibiting immune cell infiltration and activation. The gene discussed is CDK4; the disease is neoplasm.